Full in-frame exon 3 skipping of brca2 confers high risk of breast and/or ovarian cancer

Impact Journals, Oncotarget, 25(9), p. 17334-17348, 2018

Journal article published in 2018 by Sandrine M. Caputo, Mélanie Léone, Francesca Damiola, Asa Ehlen, Aura Carreira, Pascaline Gaidrat, Alexandra Martins, Rita D. Brandão, Ana Peixoto, Ana Vega, Claude Houdayer, Capucine Delnatte, Myriam Bronner, Danièle Muller, Laurent Castera and other authors.

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving forbidden

Published version: archiving allowed

Upload

Policy details

Data provided by